These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 9326240)

  • 41. Retinoic acid targets DNA-methyltransferases and histone deacetylases during APL blast differentiation in vitro and in vivo.
    Fazi F; Travaglini L; Carotti D; Palitti F; Diverio D; Alcalay M; McNamara S; Miller WH; Lo Coco F; Pelicci PG; Nervi C
    Oncogene; 2005 Mar; 24(11):1820-30. PubMed ID: 15688037
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Histone deacetylase-targeted treatment restores retinoic acid signaling and differentiation in acute myeloid leukemia.
    Ferrara FF; Fazi F; Bianchini A; Padula F; Gelmetti V; Minucci S; Mancini M; Pelicci PG; Lo Coco F; Nervi C
    Cancer Res; 2001 Jan; 61(1):2-7. PubMed ID: 11196162
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overexpression of wild-type retinoic acid receptor alpha (RARalpha) recapitulates retinoic acid-sensitive transformation of primary myeloid progenitors by acute promyelocytic leukemia RARalpha-fusion genes.
    Du C; Redner RL; Cooke MP; Lavau C
    Blood; 1999 Jul; 94(2):793-802. PubMed ID: 10397747
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Differentiation response of acute promyelocytic leukemia cells and PML/RARa leukemogenic activity studies by real-time RT-PCR.
    Caprodossi S; Pedinotti M; Amantini C; Santoni G; Minucci S; Pelicci PG; Fanelli M
    Mol Biotechnol; 2005 Jul; 30(3):231-8. PubMed ID: 15988048
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative analysis of genes regulated by PML/RAR alpha and PLZF/RAR alpha in response to retinoic acid using oligonucleotide arrays.
    Park DJ; Vuong PT; de Vos S; Douer D; Koeffler HP
    Blood; 2003 Nov; 102(10):3727-36. PubMed ID: 12893766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.
    Melnick A; Carlile GW; McConnell MJ; Polinger A; Hiebert SW; Licht JD
    Blood; 2000 Dec; 96(12):3939-47. PubMed ID: 11090081
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myeloperoxidase: expression and modulation in a large panel of human leukemia-lymphoma cell lines.
    Hu ZB; Ma W; Uphoff CC; Metge K; Gignac SM; Drexler HG
    Blood; 1993 Sep; 82(5):1599-607. PubMed ID: 8395912
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retinoic acid receptor alpha in acute promyelocytic leukaemia.
    de Thé H; Dejean A
    Cancer Surv; 1992; 14():195-203. PubMed ID: 1330303
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anticoagulant effects of retinoic acids on leukemia cells.
    Saito T; Koyama T; Nagata K; Kamiyama R; Hirosawa S
    Blood; 1996 Jan; 87(2):657-65. PubMed ID: 8555488
    [TBL] [Abstract][Full Text] [Related]  

  • 50. All-trans-retinoic acid induces CD52 expression in acute promyelocytic leukemia.
    Li SW; Tang D; Ahrens KP; She JX; Braylan RC; Yang L
    Blood; 2003 Mar; 101(5):1977-80. PubMed ID: 12393392
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Myeloperoxidase cytochemical negativity: an unexpected but intrinsic property of blasts of all phases of chronic myeloid leukemia.
    Anand M; Ghara N; Kumar R; Singh S; Sengar M; Panikar N; Raina V; Sharma A
    Ann Hematol; 2005 Nov; 84(12):767-70. PubMed ID: 15990995
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human myeloperoxidase gene expression in acute leukemia.
    Zaki SR; Austin GE; Swan D; Srinivasan A; Ragab AH; Chan WC
    Blood; 1989 Nov; 74(6):2096-102. PubMed ID: 2553160
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.
    Rego EM; Ruggero D; Tribioli C; Cattoretti G; Kogan S; Redner RL; Pandolfi PP
    Oncogene; 2006 Mar; 25(13):1974-9. PubMed ID: 16331271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. DNA methylation changes are a late event in acute promyelocytic leukemia and coincide with loss of transcription factor binding.
    Schoofs T; Rohde C; Hebestreit K; Klein HU; Göllner S; Schulze I; Lerdrup M; Dietrich N; Agrawal-Singh S; Witten A; Stoll M; Lengfelder E; Hofmann WK; Schlenke P; Büchner T; Hansen K; Berdel WE; Rosenbauer F; Dugas M; Müller-Tidow C
    Blood; 2013 Jan; 121(1):178-87. PubMed ID: 23152544
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biosynthesis and processing of myeloperoxidase--a marker for myeloid cell differentiation.
    Nauseef WM; Olsson I; Arnljots K
    Eur J Haematol; 1988 Feb; 40(2):97-110. PubMed ID: 2831080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Transgenic expression of PML/RARalpha impairs myelopoiesis.
    Early E; Moore MA; Kakizuka A; Nason-Burchenal K; Martin P; Evans RM; Dmitrovsky E
    Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7900-4. PubMed ID: 8755574
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Reduced PU.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARalpha.
    Walter MJ; Park JS; Ries RE; Lau SK; McLellan M; Jaeger S; Wilson RK; Mardis ER; Ley TJ
    Proc Natl Acad Sci U S A; 2005 Aug; 102(35):12513-8. PubMed ID: 16113082
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. The AML Cooperative Group.
    Haferlach T; Gassmann W; Löffler H; Jürgensen C; Noak J; Ludwig WD; Thiel E; Haase D; Fonatsch C; Becher R
    Ann Hematol; 1993 Apr; 66(4):165-70. PubMed ID: 8485203
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional activity of three distinct myeloperoxidase (MPO) promoters in human myeloid cells.
    Lin KM; Austin GE
    Leukemia; 2002 Jun; 16(6):1143-53. PubMed ID: 12040446
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Defect in the regulation of 4E-BP1 and 2, two repressors of translation initiation, in the retinoid acid resistant cell lines, NB4-R1 and NB4-R2.
    Grolleau A; Wietzerbin J; Beretta L
    Leukemia; 2000 Nov; 14(11):1909-14. PubMed ID: 11069026
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.